Results per Page:
Exposing viral vulnerabilities for targeted cancer vaccines
From the Boonyaratanakornkit, Phipps, Pancera, and McGuire Labs, Vaccine and Infectious Disease Division
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses